Checchi Capital Advisers’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$270K	Buy	14,591 +786	+6%	+$13.8K	0.01%	495
2025 Q4	$215K	Sell	13,805 -385	-3%	-$5.5K	0.01%	512
2025 Q3	$208K	Buy	14,190 +2,054	+17%	+$30.5K	0.01%	532
2025 Q2	$188K	Buy	12,136 +224	+2%	+$3.31K	0.01%	560
2025 Q1	$177K	Buy	+11,912	New	+$167K	0.01%	566
2024 Q1	–	Sell	-12,746	Closed	-$182K	–	592
2023 Q4	$182K	Sell	12,746 -3,377	-21%	-$47.9K	0.01%	535
2023 Q3	$249K	Buy	16,123 +1,633	+11%	+$25.3K	0.02%	447
2023 Q2	$228K	Buy	14,490 +758	+6%	+$12.4K	0.02%	502
2023 Q1	$226K	Sell	13,732 -41	-0.3%	-$653	0.02%	502
2022 Q4	$215K	Sell	13,773 -136	-1%	-$1.9K	0.02%	500
2022 Q3	$180K	Buy	13,909 +495	+4%	+$6.88K	0.02%	522
2022 Q2	$196K	Buy	13,414 +447	+3%	+$6.38K	0.02%	557
2022 Q1	$186K	Buy	12,967 +1,518	+13%	+$22.3K	0.02%	529
2021 Q4	$156K	Sell	11,449 -5,614	-33%	-$78.8K	0.01%	522
2021 Q3	$279K	Buy	17,063 +26	+0.2%	+$436	0.03%	386
2021 Q2	$287K	Sell	17,037 -285	-2%	-$4.85K	0.03%	387
2021 Q1	$316K	Buy	17,322 +13	+0.1%	+$234	0.03%	340
2020 Q4	$315K	Sell	17,309 -2,733	-14%	-$48K	0.03%	325
2020 Q3	$358K	Sell	20,042 -537	-3%	-$9.78K	0.04%	263
2020 Q2	$369K	Buy	20,579 +937	+5%	+$16.8K	0.04%	258
2020 Q1	$298K	Buy	19,642 +1,175	+6%	+$21.3K	0.03%	252
2019 Q4	$364K	Buy	18,467 +3,990	+28%	+$76.3K	0.05%	260
2019 Q3	$249K	Buy	14,477 +547	+4%	+$9.46K	0.03%	338
2019 Q2	$247K	Sell	13,930 -2,302	-14%	-$41.9K	0.03%	342
2019 Q1	$331K	Buy	+16,232	New	+$327K	0.04%	270